These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22082891)

  • 1. Management and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factors.
    Kirigaya D; Nakayama T; Ishizaki T; Ikeda S; Satoh T
    Intern Med; 2011; 50(22):2793-800. PubMed ID: 22082891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guideline adherence by physicians for management of glucocorticoid-induced osteoporosis in Japan: a nationwide health insurance claims database study.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Kamiya K; Ogawa S
    Osteoporos Int; 2022 May; 33(5):1097-1108. PubMed ID: 35022812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How to prevent glucocorticoid-induced osteoporosis.
    Dore RK
    Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bisphosphonates and dual-energy X-ray absorptiometry scans in the prevention and treatment of glucocorticoid-induced osteoporosis in rheumatology.
    Wall E; Walker-Bone K
    QJM; 2008 Apr; 101(4):317-23. PubMed ID: 18270228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Guidelines for the treatment of glucocorticoid-induced osteoporosis and their future problems].
    Soen S
    Clin Calcium; 2006 Nov; 16(11):1788-96. PubMed ID: 17079844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of Glucocorticoid-Induced Osteoporosis: Clinical audit to evaluate the implementation of National Osteoporosis Guideline Group 2017 guidelines in a primary care setting.
    Carter M
    J Clin Densitom; 2019; 22(1):25-30. PubMed ID: 29729949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).
    Majumdar SR; Lix LM; Yogendran M; Morin SN; Metge CJ; Leslie WD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1236-42. PubMed ID: 22298803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
    Feldstein AC; Elmer PJ; Nichols GA; Herson M
    Osteoporos Int; 2005 Dec; 16(12):2168-74. PubMed ID: 16142501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ; Clarke K
    J Clin Rheumatol; 2009 Mar; 15(2):61-4. PubMed ID: 19265346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline Promotion Increases Prescription of Bone Protection with Steroids in Hospitalised Patients.
    Harty L; Clare J; Finnerty D; van der Kamp S; Kennedy F; Callanan I; McKenna MJ; FitzGerald O
    Ir Med J; 2015; 108(7):216-7. PubMed ID: 26349354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoporosis management among chronic glucocorticoid users: a systematic review.
    Albaum JM; Youn S; Levesque LE; Gershon AS; Cadarette SM
    J Popul Ther Clin Pharmacol; 2014; 21(3):e486-504. PubMed ID: 25527817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-induced osteoporosis: unawareness or negligence in India?
    Gera C; Vij AS
    Int J Rheum Dis; 2009 Sep; 12(3):230-3. PubMed ID: 20374351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid-induced osteoporosis: an update on current pharmacotherapy and future directions.
    Bultink IE; Baden M; Lems WF
    Expert Opin Pharmacother; 2013 Feb; 14(2):185-97. PubMed ID: 23317448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced osteoporosis management among seniors, by year, sex, and indication, 1996-2012.
    Albaum JM; Lévesque LE; Gershon AS; Liu G; Cadarette SM
    Osteoporos Int; 2015 Dec; 26(12):2845-52. PubMed ID: 26138581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary osteoporosis UPDATE. Clinical significance of glucocorticoid-induced osteoporosis].
    Suzuki Y; Sato S
    Clin Calcium; 2010 May; 20(5):645-53. PubMed ID: 20445275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of glucocorticoid-induced osteoporosis: experience in a managed care setting.
    Yood RA; Harrold LR; Fish L; Cernieux J; Emani S; Conboy E; Gurwitz JH
    Arch Intern Med; 2001 May; 161(10):1322-7. PubMed ID: 11371261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid and bone].
    Soen S
    Clin Calcium; 2014 Jun; 24(6):829-36. PubMed ID: 24870833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of glucocorticoid-induced osteoporosis in male veterans.
    Elliott ME; Farrah RM; Binkley NC; Carnes ML; Gudmundsson A
    Ann Pharmacother; 2000 Dec; 34(12):1380-4. PubMed ID: 11144692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis].
    Suzuki Y
    Clin Calcium; 2014 Sep; 24(9):1309-18. PubMed ID: 25177003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.